pd 153035 has been researched along with saracatinib in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chu, JJ; Yang, PL | 1 |
Das, D; Hong, J | 1 |
Asquith, CRM; Drewry, DH; East, MP; Havener, TM; Johnson, GL; Laitinen, T; Morris, DC; Naegeli, KM; Wells, CI; Zuercher, WJ | 1 |
1 review(s) available for pd 153035 and saracatinib
Article | Year |
---|---|
Recent advancements of 4-aminoquinazoline derivatives as kinase inhibitors and their applications in medicinal chemistry.
Topics: Animals; Antineoplastic Agents; Chemistry Techniques, Synthetic; Humans; Neoplasms; Protein Kinase Inhibitors; Quinazolines | 2019 |
2 other study(ies) available for pd 153035 and saracatinib
Article | Year |
---|---|
c-Src protein kinase inhibitors block assembly and maturation of dengue virus.
Topics: Animals; Chlorocebus aethiops; CSK Tyrosine-Protein Kinase; Cytotoxicity Tests, Immunologic; Dasatinib; Dengue Virus; Fluorescent Antibody Technique, Indirect; Humans; Microscopy, Electron, Transmission; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; RNA Interference; src-Family Kinases; Thiazoles; Vero Cells; Virus Assembly | 2007 |
Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma.
Topics: Aminoquinolines; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chordoma; Drug Design; ErbB Receptors; HEK293 Cells; Humans; Intracellular Signaling Peptides and Proteins; Molecular Docking Simulation; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Quinazolines | 2019 |